OTUD7B Antibody - #DF12218
製品説明
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
引用形式: Affinity Biosciences Cat# DF12218, RRID:AB_2845023.
折りたたみ/展開
Cellular zinc finger anti NF kappa B protein; Cellular zinc finger anti-NF-kappa-B protein; CEZANNE; HGNC:16683; OTU domain containing protein 7B; OTU domain-containing protein 7B; OTU7B_HUMAN; OTUD7B; ZA20D1; Zinc finger A20 domain containing protein 1; Zinc finger A20 domain-containing protein 1; Zinc finger protein Cezanne;
免疫原
Widely expressed. Abundant in kidney, heart and fetal liver. Expressed differentially among B-cells at distinct developmental stages. Higher expression seen in primary immature B-cells as compared to the mature cells.
- Q6GQQ9 OTU7B_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
MTLDMDAVLSDFVRSTGAEPGLARDLLEGKNWDVNAALSDFEQLRQVHAGNLPPSFSEGSGGSRTPEKGFSDREPTRPPRPILQRQDDIVQEKRLSRGISHASSSIVSLARSHVSSNGGGGGSNEHPLEMPICAFQLPDLTVYNEDFRSFIERDLIEQSMLVALEQAGRLNWWVSVDPTSQRLLPLATTGDGNCLLHAASLGMWGFHDRDLMLRKALYALMEKGVEKEALKRRWRWQQTQQNKESGLVYTEDEWQKEWNELIKLASSEPRMHLGTNGANCGGVESSEEPVYESLEEFHVFVLAHVLRRPIVVVADTMLRDSGGEAFAPIPFGGIYLPLEVPASQCHRSPLVLAYDQAHFSALVSMEQKENTKEQAVIPLTDSEYKLLPLHFAVDPGKGWEWGKDDSDNVRLASVILSLEVKLHLLHSYMNVKWIPLSSDAQAPLAQPESPTASAGDEPRSTPESGDSDKESVGSSSTSNEGGRRKEKSKRDREKDKKRADSVANKLGSFGKTLGSKLKKNMGGLMHSKGSKPGGVGTGLGGSSGTETLEKKKKNSLKSWKGGKEEAAGDGPVSEKPPAESVGNGGSKYSQEVMQSLSILRTAMQGEGKFIFVGTLKMGHRHQYQEEMIQRYLSDAEERFLAEQKQKEAERKIMNGGIGGGPPPAKKPEPDAREEQPTGPPAESRAMAFSTGYPGDFTIPRPSGGGVHCQEPRRQLAGGPCVGGLPPYATFPRQCPPGRPYPHQDSIPSLEPGSHSKDGLHRGALLPPPYRVADSYSNGYREPPEPDGWAGGLRGLPPTQTKCKQPNCSFYGHPETNNFCSCCYREELRRREREPDGELLVHRF
種類予測
Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.
High(score>80) Medium(80>score>50) Low(score<50) No confidence
PTMs - Q6GQQ9 基板として
Site | PTM Type | Enzyme | Source |
---|---|---|---|
K30 | Ubiquitination | Uniprot | |
S55 | Phosphorylation | Uniprot | |
T65 | Phosphorylation | Uniprot | |
T76 | Phosphorylation | Uniprot | |
K93 | Ubiquitination | Uniprot | |
S100 | Phosphorylation | Uniprot | |
S103 | Phosphorylation | Uniprot | |
S104 | Phosphorylation | Uniprot | |
S105 | Phosphorylation | Uniprot | |
S149 | Phosphorylation | Uniprot | |
S159 | Phosphorylation | Uniprot | |
Y218 | Phosphorylation | Uniprot | |
K223 | Ubiquitination | Uniprot | |
K256 | Ubiquitination | Uniprot | |
K263 | Ubiquitination | Uniprot | |
T371 | Phosphorylation | Uniprot | |
K372 | Ubiquitination | Uniprot | |
K385 | Ubiquitination | Uniprot | |
K397 | Ubiquitination | Uniprot | |
S449 | Phosphorylation | Uniprot | |
T451 | Phosphorylation | Uniprot | |
S453 | Phosphorylation | Uniprot | |
S460 | Phosphorylation | Uniprot | |
T461 | Phosphorylation | Uniprot | |
S464 | Phosphorylation | Uniprot | |
S467 | Phosphorylation | Uniprot | |
S471 | Phosphorylation | Uniprot | |
S501 | Phosphorylation | Uniprot | |
K505 | Ubiquitination | Uniprot | |
S508 | Phosphorylation | Uniprot | |
K511 | Ubiquitination | Uniprot | |
K531 | Ubiquitination | Uniprot | |
T547 | Phosphorylation | Uniprot | |
S555 | Phosphorylation | Uniprot | |
S633 | Phosphorylation | Uniprot | |
K644 | Ubiquitination | Uniprot | |
K651 | Ubiquitination | Uniprot | |
K665 | Ubiquitination | Uniprot | |
K666 | Ubiquitination | Uniprot | |
R700 | Methylation | Uniprot | |
S745 | Phosphorylation | Uniprot | |
Y779 | Phosphorylation | Uniprot |
研究背景
Negative regulator of the non-canonical NF-kappa-B pathway that acts by mediating deubiquitination of TRAF3, an inhibitor of the NF-kappa-B pathway, thereby acting as a negative regulator of B-cell responses. In response to non-canonical NF-kappa-B stimuli, deubiquitinates 'Lys-48'-linked polyubiquitin chains of TRAF3, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Negatively regulates mucosal immunity against infections (By similarity). Deubiquitinates ZAP70, and thereby regulates T cell receptor (TCR) signaling that leads to the activation of NF-kappa-B. Plays a role in T cell homeostasis and is required for normal T cell responses, including production of IFNG and IL2 (By similarity). Mediates deubiquitination of EGFR. Has deubiquitinating activity toward 'Lys-11', 'Lys-48' and 'Lys-63'-linked polyubiquitin chains. Has a much higher catalytic rate with 'Lys-11'-linked polyubiquitin chains (in vitro); however the physiological significance of these data are unsure. Hydrolyzes both linear and branched forms of polyubiquitin.
Phosphorylated by EGFR.
Cytoplasm. Nucleus.
Note: Shuttles be cytoplasm and the nucleus in a XPO1/CRM1-dependent manner.
Widely expressed. Abundant in kidney, heart and fetal liver. Expressed differentially among B-cells at distinct developmental stages. Higher expression seen in primary immature B-cells as compared to the mature cells.
Interacts with ZAP70 in activated T cells, but not in resting T cells. Interacts with TRAF3 (By similarity). Interacts with TRAF6. Interacts with PARK7, leading to inhibit deubiquitinase activity. Interacts with EGFR, ITCH and NEDD4.
The protein undergoes a significant conformation change upon binding to ubiquitinated substrates. The loop that precedes the active site is in an autoinhibitory conformation in the apoprotein. Ubiquitin binding leads to a conformation change; the loop is stabilized in a catalytically competent conformation with the result that the active site Cys can form the reaction state intermediate.
Belongs to the peptidase C64 family.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.